Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
532.55
-5.28 (-0.98%)
Feb 21, 2025, 4:00 PM EST - Market closed
Thermo Fisher Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Revenue | 42,879 | 42,857 | 44,915 | 39,211 | 32,218 | Upgrade
|
Revenue Growth (YoY) | 0.05% | -4.58% | 14.55% | 21.71% | 26.14% | Upgrade
|
Cost of Revenue | 24,771 | 25,744 | 25,944 | 19,573 | 16,214 | Upgrade
|
Gross Profit | 18,108 | 17,113 | 18,971 | 19,638 | 16,004 | Upgrade
|
Selling, General & Admin | 7,011 | 8,381 | 8,940 | 7,857 | 6,940 | Upgrade
|
Research & Development | 1,390 | 1,337 | 1,471 | 1,406 | 1,181 | Upgrade
|
Other Operating Expenses | - | 1 | - | 3 | 16 | Upgrade
|
Operating Expenses | 10,353 | 9,719 | 10,411 | 9,266 | 8,137 | Upgrade
|
Operating Income | 7,755 | 7,394 | 8,560 | 10,372 | 7,867 | Upgrade
|
Interest Expense | -1,390 | -1,375 | -726 | -536 | -553 | Upgrade
|
Interest & Investment Income | 1,078 | 879 | 272 | 43 | 65 | Upgrade
|
Earnings From Equity Investments | -42 | -59 | -172 | -4 | -3 | Upgrade
|
Currency Exchange Gain (Loss) | - | -29 | 102 | 162 | - | Upgrade
|
Other Non Operating Income (Expenses) | - | 5 | -35 | -161 | 5 | Upgrade
|
EBT Excluding Unusual Items | 7,401 | 6,815 | 8,001 | 9,876 | 7,381 | Upgrade
|
Merger & Restructuring Charges | -7 | -233 | -68 | -72 | -132 | Upgrade
|
Gain (Loss) on Sale of Investments | 12 | -46 | -161 | 66 | 10 | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | 14 | - | - | Upgrade
|
Asset Writedown | - | -219 | -60 | -122 | -32 | Upgrade
|
Legal Settlements | - | -19 | - | - | - | Upgrade
|
Other Unusual Items | -411 | -59 | -63 | -911 | - | Upgrade
|
Pretax Income | 6,995 | 6,239 | 7,663 | 8,837 | 7,227 | Upgrade
|
Income Tax Expense | 657 | 284 | 703 | 1,109 | 850 | Upgrade
|
Earnings From Continuing Operations | 6,338 | 5,955 | 6,960 | 7,728 | 6,377 | Upgrade
|
Net Income to Company | 6,338 | 5,955 | 6,960 | 7,728 | 6,377 | Upgrade
|
Minority Interest in Earnings | -3 | 40 | -10 | -3 | -2 | Upgrade
|
Net Income | 6,335 | 5,995 | 6,950 | 7,725 | 6,375 | Upgrade
|
Net Income to Common | 6,335 | 5,995 | 6,950 | 7,725 | 6,375 | Upgrade
|
Net Income Growth | 5.67% | -13.74% | -10.03% | 21.18% | 72.48% | Upgrade
|
Shares Outstanding (Basic) | 382 | 386 | 392 | 394 | 396 | Upgrade
|
Shares Outstanding (Diluted) | 383 | 388 | 394 | 397 | 399 | Upgrade
|
Shares Change (YoY) | -1.29% | -1.52% | -0.76% | -0.50% | -0.99% | Upgrade
|
EPS (Basic) | 16.58 | 15.53 | 17.73 | 19.61 | 16.10 | Upgrade
|
EPS (Diluted) | 16.53 | 15.45 | 17.63 | 19.46 | 15.96 | Upgrade
|
EPS Growth | 6.99% | -12.37% | -9.40% | 21.93% | 74.05% | Upgrade
|
Free Cash Flow | 7,267 | 6,927 | 6,911 | 6,789 | 6,815 | Upgrade
|
Free Cash Flow Per Share | 18.97 | 17.85 | 17.54 | 17.10 | 17.08 | Upgrade
|
Dividend Per Share | 1.560 | 1.400 | 1.200 | 1.040 | 0.880 | Upgrade
|
Dividend Growth | 11.43% | 16.67% | 15.38% | 18.18% | 15.79% | Upgrade
|
Gross Margin | 42.23% | 39.93% | 42.24% | 50.08% | 49.67% | Upgrade
|
Operating Margin | 18.09% | 17.25% | 19.06% | 26.45% | 24.42% | Upgrade
|
Profit Margin | 14.77% | 13.99% | 15.47% | 19.70% | 19.79% | Upgrade
|
Free Cash Flow Margin | 16.95% | 16.16% | 15.39% | 17.31% | 21.15% | Upgrade
|
EBITDA | 10,856 | 10,800 | 11,941 | 12,964 | 10,192 | Upgrade
|
EBITDA Margin | 25.32% | 25.20% | 26.59% | 33.06% | 31.63% | Upgrade
|
D&A For EBITDA | 3,101 | 3,406 | 3,381 | 2,592 | 2,325 | Upgrade
|
EBIT | 7,755 | 7,394 | 8,560 | 10,372 | 7,867 | Upgrade
|
EBIT Margin | 18.09% | 17.25% | 19.06% | 26.45% | 24.42% | Upgrade
|
Effective Tax Rate | 9.39% | 4.55% | 9.17% | 12.55% | 11.76% | Upgrade
|
Revenue as Reported | - | 42,857 | 44,915 | 39,211 | 32,218 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.